Osaic Holdings
AGRX

Osaic Holdings’s Agile Therapeutics AGRX Stock Holding History

Osaic Holdings’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$7 – 7552
2023
Q4 		$7 Sell
4
-1
-20% -$2 ﹤0.01% 7249
2023
Q3 		$11 Sell
5
-12
-71% -$30 ﹤0.01% 7336
2023
Q2 		$48 Sell
17
-2
-11% -$11 ﹤0.01% 7331
2023
Q1 		$212 Hold
19
– – ﹤0.01% 7257
2022
Q4 		$0 Sell
19
-4
-17% -$47 ﹤0.01% 7606
2022
Q3 		$0 Hold
23
– – ﹤0.01% 7669
2022
Q2 		$1K Sell
23
-13
-36% -$1.89K ﹤0.01% 7236
2022
Q1 		$15K Hold
36
– – ﹤0.01% 5906
2021
Q4 		$36K Buy
36
+2
+6% +$2.82K ﹤0.01% 5400
2021
Q3 		$66K Hold
34
– – ﹤0.01% 4896
2021
Q2 		$91K Hold
34
– – ﹤0.01% 4560
2021
Q1 		$143K Sell
34
-34
-50% -$184K ﹤0.01% 4052
2020
Q4 		$392K Sell
68
-1
-1% -$5.89K ﹤0.01% 2869
2020
Q3 		$419K Buy
69
+4
+6% +$22.9K ﹤0.01% 2595
2020
Q2 		$361K Sell
65
-10
-13% -$52K ﹤0.01% 2620
2020
Q1 		$276K Buy
+75
New +$430K ﹤0.01% 2597

Other funds holding AGRX

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Osaic Holdings's AGRX Position: Q1 2024 in Review

Osaic Holdings sold out of Agile Therapeutics (AGRX) in Q1 2024, closing a stake of 4 shares — an estimated $7 sold.

Osaic Holdings first reported a position in AGRX in Q1 2020 and held it in 16 quarters. The position peaked at $419K in Q3 2020. 1 fund tracked by Wall St. Rank holds AGRX as of Q1 2024.

  • Osaic Holdings reported no remaining Agile Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 4 Agile Therapeutics shares in Q1 2024, an estimated $7.
  • Osaic Holdings first reported a position in Agile Therapeutics in Q1 2020 and held it in 16 quarters.
  • Osaic Holdings's Agile Therapeutics position peaked at $419K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Agile Therapeutics as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.